Novo Nordisk and Eli Lilly Redefine the Physical and Economic Shape of America
The pharmaceutical landscape in the United States has undergone a radical transformation as GLP-1 medications transition from niche clinical treatments to cultural
by 
Josh Weiner
Josh Weiner